https://biotechmorning.com/news/fda-moderna-white-house-pressure-reversal Biotech Morning en 2026-06-22T14:28:21.196Z The FDA Said No to Moderna. Then the President Called. https://biotechmorning.com/news/lsd-pill-crushes-depression-drugs-phase-3 Biotech Morning en 2026-06-22T14:27:29.516Z An LSD Pill Just Crushed Every Depression Drug in a Phase 3 Trial https://biotechmorning.com/news/novo-nordisk-cagrisema-loses-head-to-head-lilly-tirzepatide Biotech Morning en 2026-06-22T14:26:38.200Z Novo Nordisk Built a Lilly-Killer. It Just Lost the Fight. https://biotechmorning.com/news/bionyra-launches-165-million-inflammation-immunology Biotech Morning en 2026-06-22T14:25:45.411Z A French Biotech Just Raised the Biggest Series A in the Country's History. Here's the Playbook. https://biotechmorning.com/news/lilly-alzcure-alzheimer-billion-dollar-deal Biotech Morning en 2026-06-22T14:24:51.975Z Lilly's $10 Million Bet That Could Be Worth 100x More https://biotechmorning.com/news/big-pharma-106-billion-shopping-spree-2026 Biotech Morning en 2026-06-22T14:23:52.258Z Big Pharma Is on a $106 Billion Shopping Spree. Here's What They're Buying. https://biotechmorning.com/news/pfizer-innovent-10-billion-oncology-deal Biotech Morning en 2026-06-22T14:22:49.816Z Pfizer Just Bought 12 Cancer Programs in Five Months Flat https://biotechmorning.com/news/insilico-sk-biopharmaceuticals-ai-neuroimmune-deal Biotech Morning en 2026-06-22T14:21:56.437Z The $2.5 Billion Bet That AI Can Crack the Brain's Immune System https://biotechmorning.com/news/fda-real-time-clinical-trials-initiative-2 Biotech Morning en 2026-06-22T14:20:59.600Z The FDA Just Gave Itself a Live Feed Into Clinical Trials https://biotechmorning.com/news/abbvie-apogee-therapeutics-acquisition-10-billion Biotech Morning en 2026-06-22T14:20:04.273Z AbbVie Just Dropped $10.9 Billion on a Company That Didn't Exist Four Years Ago https://biotechmorning.com/news/otc-naloxone-rextovy-fda-approval Biotech Morning en 2026-06-21T14:18:47.587Z The Overdose Antidote You Can Now Buy Next to the Advil https://biotechmorning.com/news/sarepta-elevidys-gene-therapy-trial-failure-layoffs Biotech Morning en 2026-06-21T14:17:56.471Z The $2.5 Billion Bet on a Gene Therapy That Just Struck Out https://biotechmorning.com/news/astellas-vir-biotechnology-masked-t-cell-engager-deal Biotech Morning en 2026-06-21T14:17:00.099Z Astellas Just Paid $1.7B for a Drug That Plays Dead Until It Finds Cancer https://biotechmorning.com/news/novo-nordisk-vect-horus-delivery-platform-deal Biotech Morning en 2026-06-21T14:16:06.119Z Novo Nordisk Just Paid $327M for a Molecular GPS System https://biotechmorning.com/news/gsk-billion-dollar-bet-hepatitis-b-functional-cure Biotech Morning en 2026-06-21T14:15:12.551Z GSK's Billion-Dollar Bet to Cure a Disease That's Stumped Medicine for Decades